Pharmafile Logo

News and Press Releases

FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial

FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol This marks the official entry of NUZ-001 as Regimen I in the...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: December 11, 2025

Neurizon Therapeutics
enquiries@neurizon.com
Level 4, 96-100 Albert Road South Melbourne, VIC 3205 Australia

Iksuda Therapeutics receives FDA IND clearance for IKS014

FDA decision will enable Iksuda to expand its ongoing clinical trial in the US, Australia and Singapore Preliminary data from an ongoing dose-escalation study of IKS014 has shown meaningful clinical activity across...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: July 1, 2025

Iksuda
The Biosphere, Draymans Way, Newcastle Helix Newcastle upon Tyne NE4 5BX

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan to initiate dosing of Phase...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 2, 2024

Recursion
info@recursion.com
41 S Rio Grande Street Salt Lake City, UT 84101

Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors

Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones 11 Sep 2024 -- London, UK -- Closed Loop Medicine Ltd.,...

Category: Biotechnology, Other, Pharmaceutical
Posted: September 11, 2024

Closed Loop Medicine
info@closedloopmedicine.com
Babraham Research Campus Cambridge CB22 3AT United Kingdom

Closed Loop Medicine appoints Paul Johnson as Non-Executive Director

Appointment of digital healthcare leader to Board to support the company as it enters next phase of commercial development Co-founder and former CEO of Lemonaid Health, a leading innovator in...

Category: Biotechnology, Pharmaceutical
Posted: May 22, 2024

Closed Loop Medicine
info@closedloopmedicine.com
Babraham Research Campus Cambridge CB22 3AT United Kingdom

Abzena launches AbZelect platforms for improving cell line development efficiency on the pathway to IND

16 January 2023 -- California, US -- Abzena, the leading end-to-end CDMO for biologics and bioconjugates, has launched AbZelect and AbZelectPRO cell line development (CLD) platforms for accelerating the generation...

Category: Biotechnology
Posted: January 16, 2024

Abzena
Babraham Research Campus, Cambridge, CB22 3AT United Kingdom